| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Aztiq Pharma Partners SARL
|
103.849m | 29.10% | — | Mar 06 2026 |
| 2 |
Celtic Holdings SCA
|
90.310m | 25.31% | +305.000k | Mar 06 2026 |
| 3 |
Vanguard Capital Management, LLC
|
3.410m | 0.96% | +3.410m | Mar 31 2026 |
| 4 |
Bracebridge Capital, LLC
|
2.705m | 0.76% | — | Mar 31 2026 |
| 5 |
Millennium Management LLC
|
2.123m | 0.59% | +1.765m | Mar 31 2026 |
|
1
Aztiq Pharma Partners SARL
|
29.10%
103.849m
|
|
2
Celtic Holdings SCA
|
25.31%
90.310m
|
|
3
Vanguard Capital Management, LLC
|
0.96%
3.410m
|
|
4
Bracebridge Capital, LLC
|
0.76%
2.705m
|
|
5
Millennium Management LLC
|
0.59%
2.123m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 56.72% of Alvotech, with Aztiq Pharma Partners SARL the biggest at 29.10%, followed by Celtic Holdings SCA (25.31%) and Vanguard Capital Management, LLC (0.96%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


